Filana Therapeutics, Inc.
FLNA
$1.91
-$0.09-4.50%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -273.73% | -500.27% | -701.24% | -51.95% | 74.96% |
| Total Depreciation and Amortization | -17.31% | -32.49% | -29.68% | -28.21% | -26.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 121.31% | 120.89% | 121.12% | -24.92% | -2,103.75% |
| Change in Net Operating Assets | 2,191.02% | -95.64% | -81.38% | 284.26% | -120.13% |
| Cash from Operations | 72.42% | -7.42% | -11.17% | -24.17% | -42.55% |
| Capital Expenditure | -464.08% | -57.47% | 19.57% | -80.70% | 75.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -464.08% | -57.47% | 19.57% | -80.70% | 75.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.93% | -99.19% | -99.19% | 315.31% | 4,762.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.19% | -99.19% | -99.19% | 315.31% | 4,762.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -544.64% | -277.79% | -344.28% | 89.19% | 109.31% |